PDF ALTEA THERAPEUTICS REPORTS POSITIVE RESULTS FOR BASAL INSULIN TRANSDERMAL PATCH 3 2 pdf
Size: 15 KB
Pages: 1
Date: 2011-02-17
|
|
Recommend this on Google |
Related Documents
Size: 15 KB
Pages: 1
Date: 2011-02-17
ALTEA THERAPEUTICS REPORTS POSITIVE RESULTS FOR BASAL INSULIN TRANSDERMAL Altea Therapeutics announces positive clinical results from phase.
Size: 15 KB
Pages: 1
Date: 2011-05-17
ALTEA THERAPEUTICS REPORTS POSITIVE RESULTS FOR BASAL INSULIN TRANSDERMAL Altea Therapeutics announces positive clinical results from phase.
Size: 29 KB
Pages: 6
Date: 2011-11-09
Celldex Therapeutics Reports Positive Results from Rindopepimut Phase 2 Brain Cancer Study at SNO 2010 Businesswire via BioPortfolio Celldex Therapeutics,.
Size: 54 KB
Pages: 3
Date: 2011-02-07
Size: 31 KB
Pages: 2
Date: 2012-01-13
Notes for editors: Intralymphatic immunotherapy ILIT ImVisioN is the pioneer of intralymphatic immunot herapy ILIT , a clinically proven proprietary technology for the safe.
Size: 36 KB
Pages: n/a
Date: 2012-03-02
ExonHit Therapeutics reports 2010 results Regulatory News: The Supervisory Board of ExonHit Therapeutics Paris:ALEHT Alternext: ALEHT met on March 14 to close.
Size: 593 KB
Pages: 2
Date: 2012-03-04
Highpoi n t Business Campus 100 Highpoi n tDriveSuite102 Chalfont, PA 18914 -732 - DRUG 3784 North Carolina requires employers to report DOT positive.
Size: 26 KB
Pages: 4
Date: 2012-01-18
Exact Sciences Reports Positive Results for Colorectal Cancer Screening Test Businesswire via BioPortfolio Exact Sciences Nasdaq: EXAS today.
Size: 24 KB
Pages: 3
Date: 2012-01-09
Nabriva Reports Positive Results from Phase II Trial of Pleuromutilin Antibiotic BC-3781 in ABSSSI Businesswire via BioPortfolio Nabriva Therapeutics today.
Size: 26 KB
Pages: 4
Date: 2011-12-30
BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel R Cartilage Repair Device PR Newswire via BioPortfolio LAVAL, Canada, June.
Size: 27 KB
Pages: n/a
Date: 2012-07-09
Size: 27 KB
Pages: n/a
Date: 2012-07-01
Size: 27 KB
Pages: n/a
Date: 2013-02-27
Size: 494 KB
Pages: 5
Date: 2011-12-14
Size: 494 KB
Pages: 5
Date: 2011-10-29
Size: 494 KB
Pages: 5
Date: 2011-10-21
Size: 47 KB
Pages: n/a
Date: 2011-12-11
Size: 47 KB
Pages: n/a
Date: 2012-11-18
Size: 374 KB
Pages: 96
Date: 2011-11-18
Chapter 1 Net Assets Financial Position Results 4 Chapter 1 22Liquidity and Capital Resources1. 1. 7 22Cash Flow1. 1. 7. 1 5Managements Discussion and Analysis1. 1 of Financial Condition.
Size: 15 KB
Pages: 1
Date: 2011-04-01
ALTEA REPORTS POSITIVE PHASE I RESULTS FOR BASAL INSULIN PATCH Altea Therapeutics Drug-Delivery Insight News 01-26-2007 , January 26,2007.
Size: 22 KB
Pages: 2
Date: 2011-12-31
InteKrin Therapeutics Presents Positive INT131 Phase 2b Results at the 45th Annual European Association for the Study of Diabetes Meeting PR Newswire via BioPortfolio.
Size: 25 KB
Pages: 4
Date: 2011-12-24
Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference PR Newswire.
Size: 52 KB
Pages: 2
Date: 2011-11-25
Size: 26 KB
Pages: 3
Date: 2011-11-04
Size: 45 KB
Pages: 2
Date: 2013-05-10
Size: 46 KB
Pages: 5
Date: 2011-12-11
1 TRIUS THERAPEUTICS REPORT S 2010 SECOND QUARTER RESULTS San Diego, CA, August 19, 2010 Trius Therapeutics, Inc. Nasdaq: TSRX , a company focused.
Size: 49 KB
Pages: 5
Date: 2011-05-13
Press Release PrintPage Close Window.
Size: 29 KB
Pages: 6
Date: 2012-10-22
Opexa Therapeutics Reports Year End 2009 Financial Results Opexa Therapeutics, Inc. NASDAQ: OPXA , a company developing Tovaxin®, a novel T-cell.
Size: 33 KB
Pages: n/a
Date: 2012-07-17
Cornerstone Therapeutics Reports First Quarter 2010 Financial Results CARY, N. C. , May 4 -- Cornerstone Therapeutics Inc. Nasdaq: CRTX today reported financial.
Size: 43 KB
Pages: n/a
Date: 2012-07-17
Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results CARY, N. C. , Nov. 4 -- Cornerstone Therapeutics Inc. Nasdaq: CRTX , a specialty pharmaceutical company.
Size: 43 KB
Pages: n/a
Date: 2012-07-17
Cornerstone Therapeutics Reports Fourth Quarter and Full Year 2009 Financial Results CARY, N. C. , March 4 -- Cornerstone Therapeutics Inc. Nasdaq CM: CRTX.
Size: 30 KB
Pages: n/a
Date: 2013-03-26
Acorda Therapeutics Reports First Quarter 2010 Financial Results Acorda Therapeutics, Inc. Nasdaq: ACOR today announced its financial results.
Size: 33 KB
Pages: n/a
Date: 2013-03-26
Acorda Therapeutics Reports Fourth Quarter and Full Year 2009 Financial Results Acorda Therapeutics, Inc. Nasdaq: ACOR today announced.
Size: 38 KB
Pages: n/a
Date: 2012-12-06
Pernix Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results Pernix Therapeutics Holdings, Inc. “Pernix” or the “Company” NYSE.
Size: 151 KB
Pages: 2
Date: 2011-03-29
: GendeLLindheim BioCom Partners Barbara Lindheim 212-918-4650 TARSA THERAPEUTICS REPORTS POSI TIVETOP-LINE RESULTS FROM PIVOTAL PHASE III ORACAL.
Size: n/a
Pages: 2
Date: 2012-03-02
E u r a i l G r o u p R e p o r t s P o s i t i v e I n t e r R a i l S a l e s R e s u l t s f o r 2 0 1 1 P u b l i s h e d b y O z g u r T o r e T u e s d a y , 2 1 F e b r u a r y 2 0 1 2 2 2 : 4 6 - E u r a i l G r o u p G. I. E. , t h e o r g a n i
Size: 53 KB
Pages: 1
Date: 2012-02-20
Size: 22 KB
Pages: 2
Date: 2012-02-12
Clermont Pharmaceuticals Reports Positive Phase III Results for Drug to Treat Glaucoma TAMPA, Fla. , Sept. 26, 2011 /PRNewswire/ -- Clermont Inc. , a privately held.
Size: 24 KB
Pages: 3
Date: 2012-02-10
Viron reports positive proof of concept results in arthritis for its VT-346 anti-TNF therapeutic LONDON, ON, March 16 /PRNewswire/ - Viron Therapeutics Inc. announced.
Size: 73 KB
Pages: 3
Date: 2012-01-13
Size: 96 KB
Pages: 4
Date: 2012-01-07
Size: 36 KB
Pages: 3
Date: 2012-01-06
ABLYNX REPORT S POSITI VE PHASE I RESULTS FOR ITS ANTI-THR OMBOTIC NANOBODY ® , ALX-0081 -ends- Abou tALX-0 081.
Size: 34 KB
Pages: 3
Date: 2011-11-27
Size: 59 KB
Pages: 3
Date: 2011-11-05
  Celeste Copper Corporation, Suite 750, 71 77th Ave SW, Calgary, Alberta, T2P0Z3 Phone: 403-532-6100 Fax: 1-403- 237-6292 www. celestecopper.
Size: 20 KB
Pages: 2
Date: 2011-08-26
FOR IMMEDIATE RELEASE Contacts: Cerexa, Inc. Noonan Russo Stan Abel David Schull 510 747-3911 858 546-4810 seabel cerexa. com david. schull.
Size: 104 KB
Pages: 7
Date: 2011-08-24
-1- FOR IMMEDIATE RELEASE Tuesday, May 11, 2010 SMTC Reports Positive First Quarter Results Expects Sequential Second Quarter Revenue Growth.
Size: 354 KB
Pages: n/a
Date: 2012-07-22
Size: 44 KB
Pages: 2
Date: 2012-07-04
UK: 44 0 1202 770386 NA: 1 646 896 3065 AU 61 2 9222 2832 action. com www. co. uk 1 Year Share Price Graph Share Information Code: ATNP Listing: PLUS.
Size: 92 KB
Pages: n/a
Date: 2013-03-04
INCLUDEPICTURE cid:image003. jpg 01CD8CE0. 2B736C40 MERGEFORMAT OMNI homes seeing positive results from BSO initiative Interventions helping reduce resident.
Size: 44 KB
Pages: 2
Date: 2013-01-17
UK: 44 0 1202 770386 NA: 1 646 896 3065 AU 61 2 9222 2832 action. com www. co. uk 1 Year Share Price Graph Share Information Code: ATNP Listing: PLUS.
Comments (not logged in)